Related Experiment Video
Updated: Aug 13, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
Pharmacological control of phagocyte function: inhibition of cholesterol accumulation
R Paoletti1, S Bellosta, F Bernini
1Institute of Pharmacological Sciences, University of Milan, Italy.
Insights
Certain calcium antagonists and HMG-CoA reductase inhibitors (vastatins) can control cellular cholesterol accumulation in macrophages, offering potential pharmacological targets for atherosclerosis treatment.
Area of Science:
- Biomedical Science
- Cell Biology
- Pharmacology
Background:
- Mononuclear phagocyte-derived foam cells are key in atherosclerotic lesion development.
- Macrophages accumulate cholesterol during atherogenesis, contributing to plaque instability.
- Targeting macrophage cholesterol accumulation is a strategy against atherosclerosis.
Purpose of the Study:
- To investigate the effects of calcium antagonists on cholesterol esterification in macrophages.
- To evaluate the impact of HMG-CoA reductase inhibitors (vastatins) on cholesterol deposition in macrophages.
Main Methods:
- Cultured human and murine macrophages were used.
- Studied the effect of calcium antagonists on cellular cholesterol esterification.
- Assessed the inhibition of modified LDL endocytosis by fluvastatin and simvastatin.
Main Results:
- Vastatins (fluvastatin, simvastatin) prevented cholesterol deposition in macrophages by inhibiting modified LDL endocytosis.
- Vastatin efficacy was greater in cholesterol-loaded macrophages (foam cells) than in normal cells.
- Calcium antagonists were also studied for their effects on cellular cholesterol esterification.
Conclusions:
- Pharmacological control of macrophage cholesterol accumulation is achievable in vitro using calcium antagonists and vastatins.
- These agents may offer therapeutic benefits for atherosclerosis independent of their effects on blood pressure or blood cholesterol levels.
Abstract:
Phagocytes play a major role in several diseases. In particular mononuclear phagocyte-derived foam cells have a prominent role in the development of the atherosclerotic lesions. Macrophages are present in all stages of atherogenesis; they internalize lipoproteins and accumulate cholesterol. Moreover, lipid-filled macrophages, by secreting extracellular matrix-degrading enzymes, may weaken rupture-prone atherosclerotic plaques, thus increasing the probability of precipitating atherosclerotic acute symptoms (i.e., myocardial infarction, angina, etc.). Therefore, control of cellular functions and cholesterol accumulation in macrophages represent pharmacological targets against atherosclerosis. In our laboratory we studied the effect of calcium antagonists on cellular cholesterol esterification in cultured macrophages. We also demonstrated that the HMG-CoA reductase inhibitors (vastatins) fluvastatin and simvastatin prevented cholesterol deposition in cultured human and murine macrophage by inhibiting modified LDL endocytosis. Interestingly, vastatin activity was more pronounced in cholesterol-loaded macrophages (i.e., foam cells) than in normal cells. In conclusion, in vitro pharmacological control of cholesterol accumulation in macrophages may be achieved with some calcium antagonists and vastatins independently of their effects on blood pressure or cholesterolemia.
Related Concept Videos
Receptor-mediated Endocytosis
Inflammation
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cholesterol: Significance and Regulation
Considering cholesterol and...

